C2ORF42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.250300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.150600E-01
Normal-vs-Stage2
1.255830E-02
Normal-vs-Stage3
3.162000E-02
Normal-vs-Stage4
2.683800E-01
Stage1-vs-Stage2
4.256200E-02
Stage1-vs-Stage3
4.393600E-02
Stage1-vs-Stage4
4.825000E-01
Stage2-vs-Stage3
9.062400E-02
Stage2-vs-Stage4
6.141600E-01
Stage3-vs-Stage4
1.872810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.020300E-02
Normal-vs-AfricanAmerican
8.128300E-02
Normal-vs-Asian
6.080500E-03
Caucasian-vs-AfricanAmerican
8.783600E-01
Caucasian-vs-Asian
1.344020E-01
AfricanAmerican-vs-Asian
1.480970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.190400E-02
Normal-vs-Female
3.126000E-02
Male-vs-Female
6.584400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.208400E-01
Normal-vs-Age(41-60Yrs)
4.952300E-02
Normal-vs-Age(61-80Yrs)
1.624190E-02
Normal-vs-Age(81-100Yrs)
5.460500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.315500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.440000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.099900E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.000800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.524100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.733400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.599000E-03
Normal-vs-Daily Drinker
2.089700E-02
Normal-vs-Weekly Drinker
1.520300E-02
Normal-vs-Occasional Drinker
7.204000E-02
Normal-vs-Social Drinker
1.683970E-01
Non Drinker-vs-Daily Drinker
3.064800E-01
Non Drinker-vs-Weekly Drinker
7.319000E-01
Non Drinker-vs-Occasional Drinker
2.060600E-01
Non Drinker-vs-Social Drinker
1.237990E-02
Daily Drinker-vs-Weekly Drinker
5.811800E-01
Daily Drinker-vs-Occasional Drinker
7.156600E-01
Daily Drinker-vs-Social Drinker
9.997900E-02
Weekly Drinker-vs-Occasional Drinker
4.293800E-01
Weekly Drinker-vs-Social Drinker
5.083700E-02
Occasional Drinker-vs-Social Drinker
2.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.183800E-02
Normal-vs-Grade 2
3.484000E-02
Normal-vs-Grade 3
1.629630E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.502040E-01
Grade 1-vs-Grade 3
2.127000E-01
Grade 1-vs-Grade 4
6.183800E-02
Grade 2-vs-Grade 3
9.583400E-01
Grade 2-vs-Grade 4
3.484000E-02
Grade 3-vs-Grade 4
1.629630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.648300E-02
Normal-vs-NonDiabetic
1.395580E-02
Diabetic-vs-NonDiabetic
7.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.048400E-02
Normal-vs-NoPancreatitis
1.917550E-02
Pancreatitis-vs-NoPancreatitis
9.429800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.863900E-02
Normal-vs-N1
1.591570E-02
N0-vs-N1
4.601200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.991600E-01
Normal-vs-TP53-NonMutant
2.679600E-01
TP53-Mutant-vs-TP53-NonMutant
7.979900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
